Abstract: The invention relates to the construction of recombinant, immunodominant Rickettsia typhi proteins. The invention also relates to a method for the use of the recombinant proteins, either singly or in combination, in detection and diagnostic assays. The proteins can also be used in anti-Rickettsia typhi immunogenic formulations.
Type:
Grant
Filed:
April 27, 2009
Date of Patent:
September 6, 2011
Assignee:
The United States of America as represented by the Secretary of the Navy